Literature DB >> 10526158

Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells.

K Y Lee1, E Anderson, K Madani, G D Rosen.   

Abstract

Interferon gamma (IFN-gamma) induces apoptosis in many tumor cell lines and sensitizes tumor cells to apoptosis by tumor necrosis factor family members. IFN-gamma induces the expression of many early response genes such as interferon regulatory factor-1 (IRF-1) by activation of signal transducer and activator of transcription (STAT) factor proteins. We found that ME180 cells became resistant to IFN-gamma-induced cell death after 4-5 passages in culture. These resistant cells were characterized by a loss of STAT1 expression and a loss of inducible IRF-1 expression. We describe for the first time the emergence of a STAT1-deficient ME180 cell line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526158     DOI: 10.1016/s0014-5793(99)01283-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis.

Authors:  Sudesh Agrawal; Munna L Agarwal; Moitreyee Chatterjee-Kishore; George R Stark; Guy M Chisolm
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers.

Authors:  Edmund A Rossi; Diane L Rossi; Thomas M Cardillo; Rhona Stein; David M Goldenberg; Chien-Hsing Chang
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

3.  Activation of signal transduction and apoptosis in healthy lymphomonocytes exposed to bystander HIV-1-infected cells.

Authors:  I Abbate; F Dianzani; M R Capobianchi
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.

Authors:  Brian Giunta; Demian Obregon; Hauyan Hou; Jin Zeng; Nan Sun; Veljko Nikolic; Jared Ehrhart; Douglas Shytle; Francisco Fernandez; Jun Tan
Journal:  Brain Res       Date:  2006-10-31       Impact factor: 3.252

5.  Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies.

Authors:  Yan Ren; Piliang Hao; Bamaprasad Dutta; Esther Sok Hwee Cheow; Kae Hwan Sim; Chee Sian Gan; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2012-11-30       Impact factor: 5.911

6.  Activation of the STAT1 pathway in rheumatoid arthritis.

Authors:  P V Kasperkovitz; N L Verbeet; T J Smeets; J G I van Rietschoten; M C Kraan; T C T M van der Pouw Kraan; P P Tak; C L Verweij
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

7.  Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation.

Authors:  Xiaocai Yan; Rimas J Orentas; Bryon D Johnson
Journal:  Cytokine       Date:  2006-03-07       Impact factor: 3.861

8.  Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1.

Authors:  Y Shen; G Devgan; J E Darnell; J F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

9.  A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Authors:  Inès Souissi; Imen Najjar; Laurent Ah-Koon; Pierre Olivier Schischmanoff; Denis Lesage; Stéphanie Le Coquil; Claudine Roger; Isabelle Dusanter-Fourt; Nadine Varin-Blank; An Cao; Valeri Metelev; Fanny Baran-Marszak; Remi Fagard
Journal:  BMC Cell Biol       Date:  2011-04-12       Impact factor: 4.241

10.  Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.

Authors:  Lina Y Dimberg; Anna Dimberg; Karolina Ivarsson; Mårten Fryknäs; Linda Rickardson; Gerard Tobin; Simon Ekman; Rolf Larsson; Urban Gullberg; Kenneth Nilsson; Fredrik Öberg; Helena Jernberg Wiklund
Journal:  BMC Cancer       Date:  2012-07-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.